Vaxart
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
FINNEY MICHAEL J. director
Common Stock 1,000 N/A N/A
Option
TUCKER SEAN officer: Chief Scientific Officer
Stock Option (right to buy) 2,013 N/A N/A
Option
TUCKER SEAN officer: Chief Scientific Officer
Common Stock 2,013 N/A N/A
Purchase
COLONNESE MARK P officer: Chief Financial Officer
Common Stock 7,000 N/A N/A
Purchase
PATTI JOSEPH M director, officer: CEO
Common stock 5,000 N/A N/A
Purchase
VANLENT ANNE director
Common Stock 35,000 N/A N/A
Purchase
FOX JAMES director
Common stock 70,000 N/A N/A
Purchase
FOX JAMES director
Common stock 70,000 N/A N/A
Purchase
PATTI JOSEPH M director, officer: CEO
Common stock 20,000 N/A N/A
Purchase
PATTI JOSEPH M director, officer: CEO
Common Stock 10,000 N/A N/A
Purchase
PATTI JOSEPH M director, officer: CEO
Common Stockli 800 N/A N/A
Purchase
PATTI JOSEPH M director, officer: CEO
Common Stock 4,200 N/A N/A
Purchase
PATTI JOSEPH M director, officer: CEO
Common Stock 5,616 N/A N/A
Purchase
PLUMB RUSSELL H director
Common Stock 29,331 N/A N/A
Purchase
PATTI JOSEPH M director, officer: CEO
Common Stock 8,851 N/A N/A
Purchase
PLUMB RUSSELL H director
Common Stock 2,700 N/A N/A
Sale
KESSLER PAUL D. officer: SVP Clinical, Med. & R..
Common Stock 5,167 N/A N/A
Sale
KESSLER PAUL D. officer: SVP Clinical, Med. & R..
Common Stock 12,376 N/A N/A
Sale
KESSLER PAUL D. officer: SVP Clinical, Med. & R..
Common Stock 8,596 N/A N/A
Sale
FAHIM RAAFAT E F director, officer: President, C..
Common Stock 13,283 N/A N/A
Sale
KALNIK MATTHEW W. officer: SVP Strategic Plan. & ..
Common Stock 6,300 N/A N/A
Sale
ARYEH JASON director
Common Stock 4,900 N/A N/A
Sale
ARYEH JASON director
Common Stock 3,400 N/A N/A
Sale
ARYEH JASON director
Common Stock 24,700 N/A N/A
Sale
KESSLER PAUL D. officer: SVP Clinical, Med. & R..
Common Stock 2,985 N/A N/A
Sale
FAHIM RAAFAT E F director, officer: President, C..
Common Stock 3,181 N/A N/A
Sale
ARYEH JASON director
Common Stock 15,093 N/A N/A
Sale
ARYEH JASON director
Common Stock 3,814 N/A N/A
Sale
ARYEH JASON director
Common Stock 4,705 N/A N/A
Sale
ARYEH JASON director
Common Stock 6,700 N/A N/A
Sale
ARYEH JASON director
Common Stock 2,832 N/A N/A
Sale
ARYEH JASON director
Common Stock 463 N/A N/A
Sale
ARYEH JASON director
Common Stock 4,900 N/A N/A
Sale
ARYEH JASON director
Common Stock 4,900 N/A N/A
Sale
ARYEH JASON director
Common Stock 11,200 N/A N/A
Sale
ARYEH JASON director
Common Stock 6,400 N/A N/A
Sale
ARYEH JASON director
Common Stock 8,553 N/A N/A
Sale
ARYEH JASON director
Common Stock 12,020 N/A N/A
Sale
ARYEH JASON director
Common Stock 4,422 N/A N/A
Sale
KALNIK MATTHEW W. officer: SVP Strategic Plan. & ..
Common Stock 1,500 N/A N/A
Sale
KALNIK MATTHEW W. officer: SVP Strategic Plan. & ..
Common Stock 1,625 N/A N/A
Sale
ARYEH JASON director
Common Stock 2,747 N/A N/A
Sale
ARYEH JASON director
Common Stock 258 N/A N/A
Purchase
COX GEOFFREY F director
Common Stock 1,908 N/A N/A
Purchase
DAVIS PETER B director
Common Stock 3,816 N/A N/A
Sale
KESSLER PAUL D. officer: SVP Clinical, Med. & R..
Common Stock 15,000 N/A N/A
Sale
KALNIK MATTHEW W. officer: SVP Strategic Plan. & ..
Common Stock 2,250 N/A N/A
Sale
KESSLER PAUL D. officer: SVP Clinical, Med. & R..
Common Stock 5,248 N/A N/A
Sale
KALNIK MATTHEW W. officer: SVP Strategic Plan. & ..
Common Stock 1,950 N/A N/A
Sale
ARYEH JASON director
Common Stock 234 N/A N/A

Showing 100 to 150 of 248 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.